Retinal nerve fibre layer thickness changes in Alzheimer's disease: Results from a 12-month prospective case series

Neurosci Lett. 2016 Aug 26:629:165-170. doi: 10.1016/j.neulet.2016.07.006. Epub 2016 Jul 6.

Abstract

Purpose: To compare the 12-month peripapillary retinal nerve fibre layer (pRNFL) thickness change between AD patients and normal subjects.

Methods: In this prospective case series, thirty-six patients with a diagnosis of mild to moderate AD and 36 age-matched control subjects were included. All the subjects underwent neuropsychological (MMSE, ADAS-Cog and CDR) and ophthalmological evaluation, including spectral domain optical coherence tomography (SD-OCT), at baseline and after 12 months.

Results: Compared with controls, AD patients had a significant reduction of the total pRNFL thickness, as well as the pRNFL thickness of the inferior and superior quadrants (p=0.04, p=0.001, and p=0.01, respectively, adjusted for baseline pRNFL measurement, age, gender, and axial length). Correlation analysis showed a significant relationship between inferior pRNFL thickness change and ADAS-Cog scores change (r=-0.35, p=0.02) as well as CDR scores at 12 months (r=-0.39, p=0.008).

Conclusions: Compared with controls, AD patients had a significant reduction in pRNFL thickness over a period of 12 months. The pRNFL reduction was more prominent in the inferior quadrant and paralleled patient's cognitive decline.

Keywords: Alzheimer’s disease; Biomarker; Optical coherence tomography; Retinal nerve fibre layer thickness.

Publication types

  • Observational Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / diagnostic imaging
  • Alzheimer Disease / pathology*
  • Alzheimer Disease / physiopathology
  • Biomarkers
  • Female
  • Humans
  • Male
  • Middle Aged
  • Nerve Fibers / pathology*
  • Neuropsychological Tests
  • Optic Nerve / pathology*
  • Prospective Studies
  • Retina / pathology*
  • Tomography, Optical Coherence
  • Vision Tests

Substances

  • Biomarkers